One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes.
Leal, Ticiana A. MD 1,; Dahlberg, Suzanne E. PhD 2,; Ramalingam, Suresh S. MD 1,,
doi : 10.1200/JCO.22.01035
Volume 40(21) pgs. 2285-2392 July 20, 2022
High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling.
DuBois, Steven G. MD 1,,; Gupta, Abha A. MD, MSc 2; Palmerini, Emanuela MD 3,
doi : 10.1200/JCO.22.00449
Financial Navigation in Cancer Care Delivery: State of the Evidence, Opportunities for Research, and Future Directions.
Offodile, Anaeze C. II MD, MPH 1,2,; Gallagher, Kathleen MPH 3; Angove, Rebekah PhD 3; Tucker-Seeley, Reginald D. ScD 4,5,; Balch, Alan PhD 3; Shankaran, Veena MD, MS 6,7,,
doi : 10.1200/JCO.21.02184
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A.
Reckamp, Karen L. MD 1,,; Redman, Mary W. PhD 2; Dragnev, Konstantin H. MD 3,; Minichiello, Katherine MS 2; Villaruz, Liza C. MD 4,; Faller, Bryan MD 5,,; Al Baghdadi, Tareq MD ,6,; Hines, Susan MD 7; Everhart, Leah BS 8; Highleyman, Louise BA 8; Papadimitrakopoulou, Vassiliki MD 9,; Gandara, David R. MD 10,; Kelly, Karen MD 10,; Herbst, Roy S. MD, PhD 11,
doi : 10.1200/JCO.22.00912
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
Koch, Raphael PhD 1; Gelderblom, Hans MD 2,; Haveman, Lianne MD 3; Brichard, Benedicte MD 4; Jurgens, Heribert MD 5; Cyprova, Sona MD 6; van den Berg, Henk MD, MMED, PhD 7; Hassenpflug, Wolf MD 8,; Raciborska, Anna MD 9; Ek, Torben MD, PhD 10; Baumhoer, Daniel MD 11; Egerer, Gerlinde MD 12; Eich, Hans Theodor MD 13; Renard, Marleen MD 14; Hauser, Peter MD 15,16; Burdach, Stefan MD 17,18,; Bovee, Judith MD 19,; Bonar, Fiona MD 20,; Reichardt, Peter MD 21,; Kruseova, Jarmila MD, PhD 6; Hardes, Jendrik MD 22,; Kuhne, Thomas MD 23,; Kessler, Torsten MD 24; Collaud, Stephane MD 25; Bernkopf, Marie PhD 26; Butterfa[latin sharp s]-Bahloul, Trude MD 27; Dhooge, Catharina MD, PhD 28; Bauer, Sebastian MD 29,30,; Kiss, Janos MD 31; Paulussen, Michael MD 32; Hong, Angela MBBS, MMed, PhD 33,34,; Ranft, Andreas Dr rer nat 30,35,36; Timmermann, Beate MD 30,36,37; Rascon, Jelena MD, PhD 38,39; Vieth, Volker MD 40; Kanerva, Jukka MD 41,; Faldum, Andreas PhD 1,; Metzler, Markus MD 42; Hartmann, Wolfgang MD 43,; Hjorth, Lars MD, PhD 44,; Bhadri, Vivek MA, MD, PhD 45,46; Dirksen, Uta MD 30,35,36,,
doi : 10.1200/JCO.21.01942
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
Burtness, Barbara MD 1,,; Rischin, Danny MBBS, FRACP, MD 2,; Greil, Richard MD 3,; Soulieres, Denis MD, MSc, FRCPC 4,; Tahara, Makoto MD, PhD 5,; de Castro Jr, Gilberto MD, PhD 6,; Psyrri, Amanda MD, PhD 7,; Brana, Irene MD, PhD 8,; Baste, Neus MD 8,; Neupane, Prakash MD 9,; Bratland, Ase MD, PhD 10,; Fuereder, Thorsten MD 11,; Hughes, Brett G.M. BSc, MBBS 12,; Mesia, Ricard MD 13,; Ngamphaiboon, Nuttapong MD 14,; Rordorf, Tamara MD 15; Wan Ishak, Wan Zamaniah MD 16,; Ge, Joy PhD 17,; Swaby, Ramona F. MD 17,; Gumuscu, Burak MD, PhD 17,; Harrington, Kevin MBBS, PhD, FRCP, FRCR 18,
doi : 10.1200/JCO.21.02198
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee, Chung-Han MD, PhD 1,2,,; Voss, Martin H. MD 1,2,; Carlo, Maria Isabel MD 1,2,; Chen, Ying-Bei MD 3; Zucker, Mark PhD 4; Knezevic, Andrea MS 4,; Lefkowitz, Robert A. MD 5,; Shapnik, Natalie BS 1; Dadoun, Chloe MD 1; Reznik, Ed PhD 4; Shah, Neil J. MD 1,2,; Owens, Colette Ngozi MD 1; McHugh, Deaglan Joseph MD 1,2,; Aggen, David Henry MD, PhD 1,2,; Laccetti, Andrew Leonard MD 1,2; Kotecha, Ritesh MD 1,2,; Feldman, Darren R. MD 1,2,; Motzer, Robert J. MD 1,2,
doi : 10.1200/JCO.21.01944
Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer: A Randomized Clinical Trial.
Kim, Young-Woo MD 1; Min, Jae-Seok MD 2; Yoon, Hong Man MD 1; An, Ji Yeong MD 3,4; Eom, Bang Wool MD 1; Hur, Hoon MD 5,; Lee, Young Joon MD 6; Cho, Gyu Seok MD 7; Park, Young-Kyu MD 8; Jung, Mi Ran MD 8; Park, Ji-Ho MD 6; Hyung, Woo Jin MD 3,; Jeong, Sang-Ho MD 6; Kook, Myeong-Cherl MD 1; Han, Mira MS 9; Nam, Byung-Ho PhD 10,11; Ryu, Keun Won MD, PhD 1,
doi : 10.1200/JCO.21.02242
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.
Mikhaeel, N. George MD 1,; Heymans, Martijn W. PhD 2; Eertink, Jakoba J. PhD 3; de Vet, Henrica C.W. PhD 2; Boellaard, Ronald PhD 4; Duhrsen, Ulrich MD 5,; Ceriani, Luca MD 6,7; Schmitz, Christine MD 5,; Wiegers, Sanne E. PhD 3; Huttmann, Andreas MD 5,; Lugtenburg, Pieternella J. MD 8,; Zucca, Emanuele MD 6,7,; Zwezerijnen, Gerben J.C. MD 4; Hoekstra, Otto S. MD 4; Zijlstra, Josee M. MD 3; Barrington, Sally F. MD 9,
doi : 10.1200/JCO.21.02063
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
de Jong, Vincent M.T. MD 1; Wang, Yuwei MSc 1; ter Hoeve, Natalie D. BSc 2; Opdam, Mark BSc 1; Stathonikos, Nikolas MSc 2,; Jozwiak, Katarzyna PhD 3; Hauptmann, Michael PhD 3; Cornelissen, Sten BSc 4; Vreuls, Willem MD 5; Rosenberg, Efraim H. PhD 6; Koop, Esther A. MD 7; Varga, Zsuzsanna MD 8,; van Deurzen, Carolien H.M. MD 9,; Mooyaart, Antien L. MD 9; Cordoba, Alicia MD 10; Groen, Emma J. MD 6; Bart, Joost MD 11; Willems, Stefan M. MD 11,; Zolota, Vasiliki MD 12; Wesseling, Jelle MD 1,6,13,; Sapino, Anna MD 14,15; Chmielik, Ewa MD 16; Ryska, Ales MD 17,; Broeks, Annegien PhD 4; Voogd, Adri C. PhD 18,19; Loi, Sherene MD 20,; Michiels, Stefan PhD 21,; Sonke, Gabe S. MD 22,; van der Wall, Elsken MD 23; Siesling, Sabine PhD 20,24; van Diest, Paul J. MD 2,; Schmidt, Marjanka K. PhD 1,25; Kok, Marleen MD 22,; Dackus, Gwen M.H.E. MD 1,2; Salgado, Roberto MD 20,26,; Linn, Sabine C. MD 1,2,22,,
doi : 10.1200/JCO.21.01536
Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update.
Seth, Rahul MD 1; Messersmith, Hans MPH 2; Funchain, Pauline MD 3,; for the Systemic Therapy for Melanoma Guideline Expert Panel
doi : 10.1200/JCO.22.00944
Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles.
Gebski, Val MStat 1,,; Obermair, Andreas MD 2,; Janda, Monika PhD 3,
doi : 10.1200/JCO.21.02750
Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?.
Chiang, Cho-Han MD; Chiang, Cho-Hsien MD; Chiang, Cho-Hung MD
doi : 10.1200/JCO.22.00179
Correspondence on Concerns About Methodology and Confounding.
Chang, Renin MD, PhD; Chen, Hui-Yuan BS; Hung, Yao-Min MD, PhD; Wei, James Cheng-Chung MD, PhD
doi : 10.1200/JCO.22.00237
Reply to C.-H. Chiang et al and R. Chang et al.
Chang, Yu-Sheng MD; Shen, Yu-Chuan MD; Chen, Jin-Hua PhD; Chang, Chi-Ching PhD
doi : 10.1200/JCO.22.00711
